Amphastar Pharmaceuticals
AMPH
AMPH
218 hedge funds and large institutions have $1.13B invested in Amphastar Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 82 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 213 → 218 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 82
Holders
218
Holding in Top 10
1
Calls
$2.23M
Puts
$581K
Top Buyers
| 1 | +$20.1M | |
| 2 | +$16.2M | |
| 3 | +$11.7M | |
| 4 |
Millennium Management
New York
|
+$9.23M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$8.46M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$12M | |
| 3 | -$6.47M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.44M |
| 5 |
Morgan Stanley
New York
|
-$3.11M |